Journal of Developmental & Behavioral Pediatrics · 2007 · 267 citations · 41 references
MedicineNutritional SciencesPediatricsChild NutritionHuman NutritionPediatric NutritionAttention-deficit/hyperactivity DisorderMicronutrient Deficiency In ChildhoodAdhd TreatmentAttention Deficit Hyperactivity Disorder ComorbidityChildhood AdhdDouble-blind TrialsFatty AcidsMicronutrient Supplementation EfficacyNutrition In Attention-deficit/hyperactivity DisorderPlacebo Comparators
METHODS: Various developmental problems including attention-deficit/hyperactivity disorder (ADHD) have been linked to biological deficiencies in polyunsaturated fatty acids (PUFAs). Additionally, there is evidence that symptoms may be reduced with PUFA supplementation. This study investigated effects of supplementation with PUFAs on symptoms typically associated with ADHD. Because nutrients work synergistically, additional effects of micronutrient supplementation were also investigated. A total of 132 Australian children aged 7 to 12 years with scores > or = 2 SD above the population average on the Conners ADHD Index participated in a randomized, placebo-controlled, double-blind intervention over 15 weeks, taking PUFAs alone, PUFAs + micronutrients, or placebo. Due to unreturned questionnaires, data were only available for 104 children. RESULTS: Significant medium to strong positive treatment effects were found on parent ratings of core ADHD symptoms, inattention, hyperactivity/impulsivity, on the Conners Parent Rating Scale (CPRS) in both PUFA treatment groups compared with the placebo group; no additional effects were found with the micronutrients. After a one-way crossover to active supplements in all groups for a further 15 weeks, these results were replicated in the placebo group, and the treatment groups continued to show significant improvements on CPRS core symptoms. No significant effects were found on Conners Teacher Rating Scales. CONCLUSION: These results add to preliminary findings that ADHD-related problems with inattention, hyperactivity, and impulsivity might respond to treatment with PUFAs and that improvements may continue with supplementation extending to 30 weeks.
41
CDC growth charts: United States.
Robert J. Kuczmarski, Cynthia L. Ogden, Laurence M. Grummer‐Strawn et al. · PubMed · 2000 · 5.2K citations
Applied multivariate statistics for the social sciences, 4th ed.
James P. Stevens · 2002 · 2.7K citations
Michael G. Sawyer, Fiona Arney, Peter Baghurst et al. · Australian & New Zealand Journal of Psychiatry · 2001 · 831 citations
Omega 3 Fatty Acids in Bipolar Disorder
Andrew L. Stoll, W. Emanuel Severus, Marlene P. Freeman et al. · Archives of General Psychiatry · 1999 · 814 citations
Assessment of children, 3rd ed.
Jerome M. Sattler · 1988 · 702 citations